Coronado Industries Retains Legal Firm Covington and Burling to Expedite FDA Approval Process.Business/Technology Editors and Health/Medical Writers FOUNTAIN HILLS, Ariz.--(BW HealthWire)--Feb. 3, 2000 Coronado Industries, Inc. (OTC OTC See: Over-the-counter. OTC See over-the-counter market (OTC). BB: CDIK), a manufacturer of proprietary pneumatic devices for the effective treatment of glaucoma glaucoma (glôkō`mə), ocular disorder characterized by pressure within the eyeball caused by an excessive amount of aqueous humor (the fluid substance filling the eyeball). , has retained the law firm of Covington and Burling Burling may refer to:
This page or section lists people with the surname Burling. If an internal link for a specific person referred you to this page, you may wish to add the given name(s) to that to expedite the FDA FDA abbr. Food and Drug Administration FDA, n.pr See Food and Drug Administration. FDA, n.pr the abbreviation for the Food and Drug Administration. approval process of their proprietary glaucoma treatment, Pneumatic Trabeculoplasty (PNT PNT Point PNT Paint (MacPaint graphic file format) PNT Patient PNT Pentagon (Washington, DC; US DoD) PNT Positioning, Navigation and Timing PNT Prime Number Theorem PNT Phenytoin (tm)). Covington and Burling is considered to be one of the pre-eminent law firms This list of the world's largest law firms by revenue is taken from The Lawyer and The American Lawyer and is ordered by 2006 revenue:[1]
Coronado President Gary Smith commented, &uot;We believe that retaining such a well qualified firm will expedite the FDA process for approval of our PNT device. The firm's expertise and knowledge of FDA requisites and processes is an invaluable asset.&uot; Covington and Burling's staff comprise some of the highest caliber attorneys specializing in FDA regulatory law, including attorney Peter Hutt, who is a past general council for the FDA and currently teaches FDA law at Harvard University. Coronado Industries, through its wholly-owned subsidiaries American Glaucoma and Opthalmic International, has developed and tested the patented procedure Pneumatic Trabeculoplasty (PNT(tm)), a non-invasive, highly effective, and low-cost alternative to traditional treatments. Currently, the Company's pneumatic suction device and treatment are available throughout the European marketplace. Coronado awaits FDA approval, upon which it will license its patented treatment procedure and equipment in the United States. For additional information, see www.coronadoindustries.com Forward-looking statements in this release are made pursuant to the &uot;safe harbor&uot; provisions of the Private Securities Litigation Reform Act The Private Securities Litigation Reform Act of 1995 (PSLRA) implemented several significant substantive changes affecting certain cases brought under the federal securities laws, including changes related to pleading, discovery, liability, class representation and awards fees and of 1995. Investors are cautioned that such forward-looking statements involve risks and uncertainties, including without limitation, continued acceptance of the Company's products, increased levels of competition for the Company, new products and technological changes, the Company's dependence on third-party suppliers, and other risks detailed from time to time in the Company's periodic reports filed with the Securities and Exchange Commission. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion